Up 144% in a Tumultuous 2020? No Surprise for ARKG

Healthcare is often viewed as a defensive sector, but it’s evolving, offering investors more credible avenues for growth. One of the prime avenues for tapping into that trend is the ARK Genomic Revolution Multi-Sector Fund (CBOE: ARKG). Genomics companies try to better understand how...